Clinical Trial Update: Pembrolizumab in Treating Patients With Hormone Receptor Positive, Localized Inflammatory Breast Cancer Who Are Receiving Hormone Therapy and Did Not Achieve a Pathological Complete Response to Chemotherapy [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating pembrolizumab in hormone receptor-positive, localized inflammatory breast cancer patients on hormone therapy who did not achieve a path…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Hormone Receptor-positive Breast Cancer
• Inflammatory Breast Cancer

Drugs mentioned

• KEYTRUDA (PEMBROLIZUMAB)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Anatomic Stage IIIB Breast Cancer AJCC v8, Anatomic Stage IIIC Breast Cancer AJCC v8 | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2026-01-22